Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

AHA comments on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system proposed rule for fiscal year 2019.
Comments to the Centers for Medicare & Medicaid Services (CMS) on the fiscal year (FY) 2019 proposed rule for the inpatient psychiatric facilities (IPF) prospective payment system (PPS) and quality reporting updates.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses
The information below supplements the March 29, 2018 memorandum AHA’s outside counsel prepared regarding 340B claims submission during the legal challenge to the 2018 outpatient prospective payment
AHA letter to the House expressing support of H.R. 6082, the Overdose Prevention and Patient Safety (OPPS) Act, which would align 42 CFR Part 2 with the Health Insurance Portability and Accountability Act (HIPAA) for the purposes of treatment, payment and health care operations.
On behalf of our nearly 5,000 member hospitals, health systems and other health care organizations, and our clinician partners – including more than 270,000 affiliated physicians, 2 million nurses and other caregivers – and the 43,000 health care leaders who belong to our professional membership groups, the American Hospital Association (AHA) is pleased to support the Stretching Entity Resources for Vulnerable (SERV) Communities Act.
Letter to the Senate Finance Committee leadership supporting the Helping to End Addiction and Lessen (HEAL) Substance Use Disorders Act of 2018.
The American Hospital Association and others support Senators Grassley and Feinstein of the Senate Judiciary Committee for their leadership and commitment to reducing out-of-control prescription dr